Download PDF
Thromb Haemost 1995; 73(01): 138-143
DOI: 10.1055/s-0038-1653739
Original Article
Platelets
Schattauer GmbH Stuttgart

A Novel Mechanism for Exposure of Fibrinogen Binding Sites on GPIIb-IIIa by a Monoclonal Antibody

Takaaki Hato
1   The Blood Transfusion Division, Ehime University School of Medicine, Ehime, Japan
,
Akito Watanabe
2   The Department of Internal Medicine I, Ehime University School of Medicine, Ehime, Japan
,
Shingo Nakatani
2   The Department of Internal Medicine I, Ehime University School of Medicine, Ehime, Japan
,
Yoko Minamoto
2   The Department of Internal Medicine I, Ehime University School of Medicine, Ehime, Japan
,
Shigeru Fujita
2   The Department of Internal Medicine I, Ehime University School of Medicine, Ehime, Japan
› Author Affiliations
Further Information

Publication History

Received 04 July 1994

Accepted after revision 09 September 1994

Publication Date:
09 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

Conformational changes in platelet membrane glycoprotein (GP) IIb-IIIa, whose nature is not defined, lead to exposure of fibrinogen binding sites. We have reported previously that F(ab’)2fragments of a monoclonal antibody, PMA4, directed against the GPIIb-IIIa complex- specific domain, induced binding of fibrinogen to platelets without causing intracellular activation, whereas Fab did not. In this study, we examined the mechanism responsible for the difference in the ability of PMA4 F(ab’)2and Fab to expose fibrinogen binding sites. PMA4 Fab had affinity for GPIIb-IIIa similar to that of PMA4 F(ab’)2. Addition of F(ab’)2goat anti-mouse Fab antibody to cross-link PMA4 Fab-bound GPIIb-IIIa molecules induced fibrinogen binding. There was a direct correlation between the number of molecules of PMA4 F(ab’)2and the amount of fibrinogen bound. PMA4 did not recognize ligand-induced binding sites (LIBS). These results suggest that the cross-linking of special sites on the GPIIb-IIIa complex-specific domain by bivalent antibody alters the conformation of GPIIb-IIIa to a state competent to bind soluble fibrinogen and that conformational changes in non-LIBS are involved in the mechanism for exposing fibrinogen binding sites on GPIIb-IIIa.

 

  • References

  • 1 Ginsberg MH, Du X, O’Toole TE, Loftus JC, Plow EF. Platelet integrins. Thromb Haemost 1993; 70: 87-93
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 Smyth SS, Joneckis CC, Parise LV. Regulation of vascular integrins. Blood 1993; 81: 2827-2843
    PubMedGoogle Scholar
  • 3 Modderman PW, Huisman HG, van Mourik JA, von dem Borne Jr AE G. A monoclonal antibody to the human platelet glycoprotein IIb-IIIa complex induces platelet activation. Thromb Haemost 1988; 60: 68-74
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Bachelot C, Rendu F, Boucheix C, Hogg N, Toledano SL. Activation of platelets induced by mAb P256 specific for glycoprotein IIb-IIIa. Possible evidence for a role for IIb-IIIa in membrane signal transduction. Eur J Biochem 1990; 190: 177-183
    CrossrefPubMedGoogle Scholar
  • 5 Gulino D, Ryckwaert JJ, Andrieux A, Rabiet MJ, Marguerie G. Identification of a monoclonal antibody against platelet GPIIb that interacts with a calcium-binding site and induces aggregation. J Biol Chem 1990; 265: 9575-9581
    PubMedGoogle Scholar
  • 6 Kouns WC, Wall CD, White MM, Fox CF, Jennings LK. A conformation-dependent epitope of human glycoprotein IIIa. J Biol Chem 1990; 265: 20594-20601
    PubMedGoogle Scholar
  • 7 Kouns WC, Jennings LK. Activation-independent exposure of the GPIIb-IIIa fibrinogen receptor. Thromb Res 1991; 63: 343-354
    CrossrefPubMedGoogle Scholar
  • 8 O'Toole TE, Loftus JC, Du X, Glass AA, Ruggeri ZM, Shattil SJ, Plow EF, Ginsberg MH. Affinity modulation of the αIIBβ3integrin (platelet GPIIb-IIIa) is an intrinsic property of the receptor. Cell Regul 1990; 1: 883-893
    CrossrefPubMedGoogle Scholar
  • 9 Frelinger III AL, Du X, Plow EF, Ginsberg MH. Monoclonal antibodies to ligand-occupied conformers of integrin αIIBβ3(Glycoprotein IIb-IIIa) alter receptor affinity, specificity and function. J Biol Chem 1991; 266: 17106-17111
    PubMedGoogle Scholar
  • 10 Watanabe A, Hato T, Kobayashi Y. Exposure of platelet fibrinogen receptors by a monoclonal antibody to the GPIIb-IIIa complex, PMA4. Int J Haematol 1992; 56: 79-87
    PubMedGoogle Scholar
  • 11 Frojmovic MM, O'Toole TE, Plow EF, Loftus JC, Ginsberg MH. Platelet glycoprotein IIb-IIIa (αIIBβ3integrin) confers fibrinogen- and activation-dependent aggregation on heterologous cells. Blood 1991; 78: 369-376
    PubMedGoogle Scholar
  • 12 Du X, Plow EF, Frelinger AL III, O'Toole TE, Loftus JC, Ginsberg MH. Ligands “activate” integrin αIIBβ3(platelet GPIIb-IIIa). Cell 1991; 65: 409-416
    CrossrefPubMedGoogle Scholar
  • 13 Pytela RP, Pierschbacher MD, Ginsberg MH, Plow EF, Ruoslahti E. Platelet membrane glycoprotein IMIIa: Member of a family of Arg-Gly-Asp-specific adhesion receptors. Science 1986; 231: 1559-1562
    CrossrefPubMedGoogle Scholar
  • 14 Lam SC-T, Plow EF, Smith MA, Andrieux A, Ryckwaert JJ, Marguerie G, Ginsberg MH. Evidence that arginyl-glycyl-aspartate peptides and fibrinogen y chain peptides share a common binding site on platelets. J Biol Chem 1987; 262: 947-950
    PubMedGoogle Scholar
  • 15 Andrieux A, Hudry-Clergeon G, Ryckwaert JJ, Chapel A, Ginsberg MH, Plow EF, Marguerie G. Amino acid sequence in fibrinogen mediating its interaction with its platelet receptor, GPIIb-IIIa. J Biol Chem 1989; 264: 9258-9265
    PubMedGoogle Scholar
  • 16 Hato T. The role of glycoprotein IIb-IIIa complex in ristocetin-stimulated platelets as revealed by a monoclonal antibody. Acta Haematol Jpn 1987; 50: 129-137
    PubMedGoogle Scholar
  • 17 Parham P. Preparation and purification of active fragments from mouse monoclonal antibodies. In: Immunochemistry. Weir DM. ed Blackwell, Oxford; 1986. pp 14.1-14.23
    Google Scholar
  • 18 Hato T, Ikeda K, Yasukawa M, Watanabe A, Kobayashi Y. Exposure of platelet fibrinogen receptors by a monoclonal antibody to CD9 antigen. Blood 1988; 72: 224-229
    PubMedGoogle Scholar
  • 19 Bennett JS, Villaire G. Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 1979; 64: 1393-1401
    CrossrefPubMedGoogle Scholar
  • 20 Hawiger J, Parkinson S, Timmons S. Prostacyclin inhibits mobilization of fibrinogen-binding sites on human ADP- and thrombin-treated platelets. Nature 1980; 283: 195-197
    CrossrefPubMedGoogle Scholar
  • 21 Parise LV, Helgerson SL, Steiner B, Nannizzi L, Phillips DR. Synthetic peptides derived from fibrinogen and fibronectin change the conformation of purified platelet glycoprotein IIb-IIIa. J Biol Chem 1987; 262: 12957-12962
    PubMedGoogle Scholar
  • 22 Frelinger AL III, Lam SC-T, Plow EF, Smith MA, Loftus JC, Ginsberg MH. Occupancy of an adhesion glycoprotein receptor modulates expression of antigenic site involved in cell adhesion. J Biol Chem 1988; 263: 12397-12402
    PubMedGoogle Scholar
  • 23 Frelinger AL III, Cohen I, Plow EF, Smith MA, Roberts J, Lam SC-T, Ginsberg MH. Selective inhibition of integrin function by antibodies specific for ligand-occupied receptor conformations. J Biol Chem 1990; 265: 6346-6352
    PubMedGoogle Scholar
  • 24 Shattil SJ, Brass LF, Bennett JS, Pandhi P. Biochemical and functional consequences of dissociation of the platelet membrane glycoprotein IIb-IIIa complex. Blood 1985; 66: 92-98
    PubMedGoogle Scholar
  • 25 Pidard D, Didry D, Kunicki TJ, Nurden AT. Temperature-dependent effects of EDTA on the membrane glycoprotein IIb-IIIa complex and platelet aggregability. Blood 1986; 67: 604-611
    PubMedGoogle Scholar
  • 26 Morel M-C, Lecompte T, Champeix P, Favier R, Potevin F, Samasa M, Salmon C, Kaplan C. PL2-49, a monoclonal antibody against glycoprotein IIb which is a platelet activator. Br J Haematol 1989; 71: 57-63
    CrossrefPubMedGoogle Scholar
  • 27 Anderson GP, van de Winkel JG J, Anderson CL. Anti-GPIIb-IIIa(CD41) monoclonal antibody-induced platelet activation requires Fc receptordependentcell-cell interaction. Br J Haematol 1991; 79: 75-83
    CrossrefPubMedGoogle Scholar
  • 28 Hornby EJ, Brown S, Wilkinson JM, Mattock C, Authi KS. Activation of human platelets by exposure to a monoclonal antibody, PM6/248, to glycoprotein IIb-IIIa. Br J Haematol 1991; 79: 277-285
    CrossrefPubMedGoogle Scholar
  • 29 Horsewood P, Hayward CP M, Warkentin TE, Kelton JG. Investigation of the mechanisms of monoclonal antibody-induced platelet activation. Blood 1991; 78: 1019-1026
    PubMedGoogle Scholar
  • 30 Stuttle AW J, Powling MJ, Ritter JM, Hardisty RM. Effects of a monoclonal antibody to glycoprotein IIb/IIIa(P256) and of enzymically derived fragments of P256 on human platelets. Thromb Haemost 1991; 65: 432-437
    Article in Thieme ConnectPubMedGoogle Scholar
  • 31 Rubinstein E, Kouns WC, Jennings LK, Boucheix C, Carroll RC. Interaction of two GPIIb/IIIa monoclonal antibodies with platelet Fc receptor (FcγRII). Br J Haematol 1991; 77: 80-86
    CrossrefPubMedGoogle Scholar
  • 32 Bachelot C, Sulpice JC, Giraud F, Rendu F. Mechanisms involved in platelet activation induced by a monoclonal antibody anti glycoprotein IIb-IIIa: inositol phosphate production is not the primary event. Cell Signalling 1991; 3: 539-546
    PubMedGoogle Scholar
  • 33 Bachelot C, Cano E, Grelac F, Saleun S, Druker BJ, Levy-Toledano S, Fischer S, Rendu F. Functional implications of tyrosine protein phosphorylation in platelets: simultaneous studies with different agonists and inhibitors. Biochem J 1992; 284: 923-928
    CrossrefPubMedGoogle Scholar
  • 34 Bennett JS. The platelet-fibrinogen interaction. In: Platelet membrane glycoproteins. George JN, Nurden AT, Phillips DR. eds Plenum; New York: 1985. pp 193-214
    Google Scholar
  • 35 Bai Y, Durbin H, Hogg N. Monoclonal antibodies specific for platelet glycoproteins react with human monocytes. Blood 1984; 64: 139-146
    PubMedGoogle Scholar
  • 36 Takada Y, Puzon W. Identification of a regulatory region of integrinβ subunit using activating and inhibiting antibodies. J Biol Chem 1993; 268: 17597-17601
    PubMedGoogle Scholar
  • 37 van de Wiel-van Kemenade E, van Kooyk Y, de Boer AJ, Huijbens RJ F, Weder P, van de Kasteele W, Melief CJ M, Figdor CG. Adhesion of T and B lymphocytes to extracellular matrix and endothelial cells can be regulated through the β subunit of VLA. J Cell Biol 1992; 117: 461-470
    CrossrefPubMedGoogle Scholar
  • 38 Martin-Padura I, Bazzoni G, Zanetti A, Bernasconi S, Elices MJ, Mantovani A, Dejana E. A novel mechanism of colon carcinoma cell adhesion to the endothelium triggered by β1integrin chain. J Biol Chem 1994; 269: 6124-6132
    PubMedGoogle Scholar
  • 39 Du X, Gu M, Weisel JW, Nagaswami C, Bennett JS, Bowditch R, Ginsberg MH. Long range propagation of conformational changes in integrin αIIbβ3 . J Biol Chem 1993; 268: 23087-23092
    PubMedGoogle Scholar